News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Simone Cesaro: The graft versus neuroblastoma effect
Photo of Simone Cesaro from aileonlus.org
Apr 11, 2024, 14:40

Simone Cesaro: The graft versus neuroblastoma effect

Simone Cesaro,

“The graft versus neuroblastoma effect is not so potent to improve the outcome of relapsed refractory neuroblastoma treated with allogeneic RIC HCT: Italian pediatric experience.”

View the article attached to the post.
Source: Simone Cesaro/LinkedIn

allogeneic RIC HCT cancer hematopoietic stem cell transplantation neuroblastoma OncoDaily Oncology pediatric experience Simone Cesaro survival
Special Coverage
Blog
Mar 29, 2025, 06:23
UICC - The Growing Global Threat of Antimicrobial Resistance in Cancer Care
Blog
Mar 29, 2025, 06:05
Yat Man Tsang: Radiation therapists’ perspectives on AI
Insight
Mar 29, 2025, 06:01
Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients
Blog
Mar 29, 2025, 04:55
Akhil Santhosh: Final overall survival results of checkmate 067 in NEJM
Blog
Mar 29, 2025, 04:16
Maximilian Merz: From student to academic physician - A 14-Year Journey at MSKCC
OncoDaily Pulse
Mar 29, 2025, 03:34
OncoDaily partners with EYOC aiming for innovation, research and equitable care
Career
Mar 29, 2025, 03:20
Nasim Eftekhari: I've been promoted to Chief AI and Analytics Officer at City of Hope
Insight
Mar 28, 2025, 20:51
Samer Al Hadidi: Check out our recent work in Blood Advances, led by Bhavesh Mohan Lal at the UAMS Myeloma Center
Blog
Mar 28, 2025, 20:17
Mustafa H. Alsaadi: Excited to share that three of our abstracts have been accepted for poster presentation at ASCO 2025
Blog
Mar 28, 2025, 20:11
Raffaele Giusti: MARIPOSA overall survival data at ELCC25
Blog
Mar 28, 2025, 19:58
Nina Niu Sanford: Here is HCC 101 video
Blog
Mar 28, 2025, 19:38
Julien Mazieres: Another brick in the wall of HER2-mutant NSCLC